Contribute Try STAT+ Today

A recent decision by one of the largest pharmacy benefit managers in the U.S. to exclude several HIV medicines from its list of drugs eligible for insurance coverage has angered AIDS advocacy groups, which argue the move may harm patients.

In two separate actions over the past few months, Express Scripts excluded seven HIV medicines for anyone starting treatment. The pharmacy benefit manager explained that less expensive alternatives are available and its decisions were supported by clinical guidelines. The company also noted the drugs remaining on its national formulary appear on federal guidelines for most patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.